← Back to Analyst Consensus 
MLAB Buy
MESA LABORATORIES INC /CO/
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 14, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Feb 4, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $94 | 54% |
| Dec 15, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $83 | 54% |
| Aug 8, 2025 | Wells Fargo | upgrade | Underweight → Equal-Weight | $67 | 54% |
| May 30, 2025 | Wells Fargo | maintain | Underweight → Underweight | $100 | 54% |
| Oct 1, 2024 | Evercore ISI Group | maintain | Outperform → Outperform | $160 | 58% |
| Aug 27, 2024 | Wells Fargo | initiate | — → Underweight | $120 | 54% |
| Aug 6, 2024 | Evercore ISI Group | maintain | Outperform → Outperform | $120 | 58% |
| Jul 2, 2024 | Evercore ISI Group | maintain | Outperform → Outperform | $106 | 58% |
| Apr 4, 2024 | Evercore ISI Group | maintain | Outperform → Outperform | $130 | 58% |
| Jan 4, 2024 | Evercore ISI Group | upgrade | In-Line → Outperform | $125 | 58% |
| Jan 4, 2021 | Evercore ISI Group | downgrade | Outperform → In-Line | $300 | 58% |
| Nov 10, 2020 | Keybanc | initiate | — → Sector Weight | $0 | 53% |
| Oct 2, 2020 | JP Morgan | initiate | — → Neutral | $260 | 54% |
| Dec 4, 2019 | Jefferies | initiate | — → Buy | $275 | 52% |
| Aug 26, 2019 | Evercore ISI Group | initiate | — → Outperform | $250 | 58% |
| Jun 10, 2016 | Sidoti & Co. | downgrade | Buy → Neutral | $0 | 38% |
| Feb 10, 2016 | Janney Montgomery Scott | initiate | — → Buy | $0 | 55% |
Price Target Trend
May 12, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days